Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Tariq Mehmood Satti"'
Autor:
Qamar Un-Nisa Choudry, Raheel Iftikhar, Manzur Qadir, Tariq Mehmood Satti, Ghassan Omair, Syed Kamran Mehmood
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 71, Iss 1, Pp 107-11 (2021)
Objective: To determine the effect of high altitude on frequency and risk factors of venous thrombosis in individuals ascending to high altitude Study Design: Cross-sectional analytical study. Place and Duration of Study: Armed Forces Bone Marr
Externí odkaz:
https://doaj.org/article/dc9c6e406b234aa5b4e2dde0d149c76d
Autor:
Nighat Shahbaz, Parvez Ahmed, Tariq Mehmood Satti, Nadeem Paracha, Syed Kamran Mehmood, Qamar Un Nisa Chaudhary, Mehreen Ali Khan, Humayyun Satti
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 70, Iss 5, Pp 1516-1521 (2020)
Objective: Retrospective analysis to evaluate overall response and outcome of various therapeutic regimens given in patients with non acute promyelocytic acute myeloid leukaemia (non APL AML). Study Design: Retrospective study. Place and Durati
Externí odkaz:
https://doaj.org/article/e53ea27bcaec4f9dac4708c9ed1b91db
Autor:
Raheel Iftikhar, Qamar un Nisa Chaudhry, Tariq Mehmood Satti, Syed Kamran Mahmood, Tariq Ghafoor, Ghassan Umair Shamshad, Nighat Shahbaz, Mehreen Ali Khan, Tariq Azam Khattak, Jahanzeb Rehman, Muhammad Farhan, Saima Humayun, Humera Haq, Syeda Ammaara Anwaar Naqvi, Faiz Anwer, Humayoon Shafique Satti, Parvez Ahmed
Publikováno v:
Clinical Hematology International, Vol 2, Iss 2 (2020)
Allogeneic stem cell transplant for high-risk aplastic anemia (AA) yields inferior results using conventional cyclophosphamide (CY)-based conditioning. The use of fludarabine (Flu)-based regimens has resulted in improved outcomes in high-risk patient
Externí odkaz:
https://doaj.org/article/d351dd7dd74c441297ae6d732ecfb695
Autor:
Raheel iftikhar, Qamar Un nisa Chaudhry, Tariq Mehmood Satti, Syed Kamran Mahmood, Tariq Ghafoor
Publikováno v:
Clinical Case Reports, Vol 7, Iss 7, Pp 1442-1444 (2019)
Key Clinical Message Post‐transplant lymphoproliferative disorders are rare but potentially life‐threatening complication of HSCT. Although not frequently reported but PTLD can occur as a late post‐transplant complication in HSCT recipients. A
Externí odkaz:
https://doaj.org/article/a592a9b8556a4e92be824b7a1bac52d1
Autor:
Manzur Qadir, Ghassan Omair, Qamar Un-Nisa Choudry, Tariq Mehmood Satti, Syed Kamran Mehmood, Raheel Iftikhar
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 71, Iss 1, Pp 107-11 (2021)
Objective: To determine the effect of high altitude on frequency and risk factors of venous thrombosis inindividuals ascending to high altitude Study Design: Cross-sectional analytical study. Place and Duration of Study: Armed Forces Bone Marrow Tran
Autor:
Jahanzeb Rehman, Mehreen Ali Khan, Nighat Shahbaz, Faiz Anwer, Muhammad Farhan, Parvez Ahmed, Tariq Azam Khattak, Saima Humayun, Ghassan Umair Shamshad, Qamar Un Nisa Chaudhry, Syed Kamran Mahmood, Ahsan Wahab, Amina Risalat, Raheel Iftikhar, Humayun Shafique Satti, Tariq Mehmood Satti, Tariq Ghafoor
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:2245-2251
Cyclosporine (CsA) combined with short-course methotrexate is considered standard-of-care graft-versus-host disease (GVHD) prophylaxis for patients with severe aplastic anemia (AA) who undergo transplantation using cyclophosphamide (Cy) plus anti-thy
Autor:
Tariq Mehmood Satti, Mehreen Ali Khan, Qamar-Un-Nisa Chaudhry, Tariq Ghafoor, Nadia Sial, Zaineb Akram, Parvez Ahmed, Nighat Shahbaz, Humayoon Shafique Satti, Salman Akbar Malik, Syed Kamran Mahmood
Publikováno v:
Regenerative Engineering and Translational Medicine. 7:234-243
Mesenchymal stromal cells (MSCs) have emerged as a promising candidate for the treatment of steroid-refractory graft-versus-host disease (GVHD). In this uncontrolled, pilot clinical study, we report safety and efficacy of allogeneic bone marrow MSCs
Autor:
Tariq Ghafoor, Mehreen Ali Khan, Muhammad Farhan, Humayoon Shafique Satti, Faiz Anwer, Tariq Mehmood Satti, Parvez Ahmed, Qamar Un Nisa Chaudhry, Ghassan Umair Shamshad, Syed Kamran Mahmood, Nighat Shahbaz, Tariq Azam Khattak, Saima Humayun, Jahanzeb Rehman, Raheel Iftikhar
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:2375-2382
Despite excellent transplant outcomes of aplastic anemia (AA) in developed countries, management in developing countries is challenging because of delay in the diagnosis, use of family donors for transfusions, and higher infection risk pretransplant.
Autor:
Tariq Mehmood Satti, Jahanzeb Rehman, Nighat Shahbaz, Ghassan Umair Shamshad, Mehreen Ali Khan, Raheel Iftikhar, Tariq Ghafoor, Syed Kamran Mahmood, Tariq Azam Khattak, Muhammad Farhan, Parvez Ahmed, Qamar Un Nisa Chaudhry
Publikováno v:
Bone marrow transplantation. 56(9)
Introduction Allogeneic hematopoietic stem cell transplant (HSCT) is the standard treatment for patients younger than 40 years with Severe and Very Severe Aplastic Anemia (AA) who have a Matched Related Donor (MRD). For patients lacking a MRD, treatm
Autor:
Tariq Ghafoor, Raheel Iftikhar, Syed Kamran Mahmood, Qamar Un Nisa Chaudhry, Tariq Mehmood Satti
Publikováno v:
Clinical Case Reports, Vol 7, Iss 7, Pp 1442-1444 (2019)
Clinical Case Reports
Clinical Case Reports
Post‐transplant lymphoproliferative disorder (PTLD) is rarely reported in matched sibling donor (MSD) transplants of aplastic anemia (AA), and occurrence of Hodgkin lymphoma in this subgroup is extremely uncommon. Our patient, a 7‐year‐old girl